124 related articles for article (PubMed ID: 3392461)
1. Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats.
Bar-Tana J; Rose-Kahn G; Frenkel B; Shafer Z; Fainaru M
J Lipid Res; 1988 Apr; 29(4):431-41. PubMed ID: 3392461
[TBL] [Abstract][Full Text] [Related]
2. The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III.
Frenkel B; Mayorek N; Hertz R; Bar-Tana J
J Biol Chem; 1988 Jun; 263(17):8491-7. PubMed ID: 3372539
[TBL] [Abstract][Full Text] [Related]
3. Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats.
Russell JC; Dolphin PJ; Hameed M; Stewart B; Koeslag DG; Rose-Kahn G; Bar-Tana J
Arterioscler Thromb; 1991; 11(3):602-9. PubMed ID: 2029500
[TBL] [Abstract][Full Text] [Related]
4. Adipose reduction by beta,beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16).
Tzur R; Smith E; Bar-Tana J
Int J Obes; 1989; 13(3):313-26. PubMed ID: 2670791
[TBL] [Abstract][Full Text] [Related]
5. The effect of beta,beta'-tetramethylhexadecanedioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: role of apolipoprotein C-III.
Frenkel B; Bishara-Shieban J; Bar-Tana J
Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):409-14. PubMed ID: 8135749
[TBL] [Abstract][Full Text] [Related]
6. Hypolipidemic, antiobesity, and hypoglycemic-hypoinsulinemic effects of beta,beta'-methyl-substituted hexadecanedioic acid in sand rats.
Tzur R; Rose-Kahn G; Adler JH; Bar-Tana J
Diabetes; 1988 Dec; 37(12):1618-24. PubMed ID: 3056760
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat liver acetyl-CoA carboxylase by beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16).
Rose-Kahn G; Bar-Tana J
Biochim Biophys Acta; 1990 Feb; 1042(2):259-64. PubMed ID: 1967952
[TBL] [Abstract][Full Text] [Related]
8. Hypocholesterolaemic effect of beta beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in the male hamster.
Mayorek N; Bar-Tana J
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):911-7. PubMed ID: 8435085
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16) on laying hen performance and egg yolk lipid composition.
Elkin RG; Rogler JC; Lee HD; Watkins BA
Br Poult Sci; 1992 Jul; 33(3):677-81. PubMed ID: 1643530
[TBL] [Abstract][Full Text] [Related]
10. Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo.
Mayorek N; Kalderon B; Itach E; Bar-Tana J
Diabetes; 1997 Dec; 46(12):1958-64. PubMed ID: 9392480
[TBL] [Abstract][Full Text] [Related]
11. Lipoproteins in experimental nephrosis: plasma levels and composition.
Marsh JB; Sparks CE
Metabolism; 1979 Oct; 28(10):1040-5. PubMed ID: 226831
[TBL] [Abstract][Full Text] [Related]
12. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.
Hertz R; Bishara-Shieban J; Bar-Tana J
J Biol Chem; 1995 Jun; 270(22):13470-5. PubMed ID: 7768950
[TBL] [Abstract][Full Text] [Related]
13. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
14. Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis.
Hirano T; Komuro F; Furukawa S; Nagano S; Takahashi T
Metabolism; 1990 Jun; 39(6):605-9. PubMed ID: 2112675
[TBL] [Abstract][Full Text] [Related]
15. Tissue selective modulation of redox and phosphate potentials by beta,beta'-methyl-substituted hexadecanedioic acid.
Kalderon B; Hertz R; Bar-Tana J
Endocrinology; 1992 Oct; 131(4):1629-35. PubMed ID: 1396307
[TBL] [Abstract][Full Text] [Related]
16. MDL 29311, a phenolic antioxidant, interferes with the interaction of apoC with VLDL: a possible explanation for its triglyceride-lowering effect.
Sheetz MJ
J Lipid Res; 1995 Dec; 36(12):2609-21. PubMed ID: 8847487
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lipid synthesis by beta beta'-tetramethyl-substituted, C14-C22, alpha, omega-dicarboxylic acids in cultured rat hepatocytes.
Rose-Kahn G; Bar-Tana J
J Biol Chem; 1985 Jul; 260(14):8411-5. PubMed ID: 4008497
[TBL] [Abstract][Full Text] [Related]
18. Effect of 3-thiadicarboxylic acid on lipid metabolism in experimental nephrosis.
al-Shurbaji A; Skorve J; Berge RK; Rudling M; Björkhem I; Berglund L
Arterioscler Thromb; 1993 Nov; 13(11):1580-6. PubMed ID: 8218098
[TBL] [Abstract][Full Text] [Related]
19. Alterations in levels and interrelations of plasma apolipoproteins induced by diet.
Schonfeld G; Weidman SW; Witztum JL; Bowen RM
Metabolism; 1976 Mar; 25(3):261-75. PubMed ID: 175240
[TBL] [Abstract][Full Text] [Related]
20. Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin.
Calandra S; Tarugi P; Ghisellini M; Gherardi E
Exp Mol Pathol; 1983 Dec; 39(3):282-99. PubMed ID: 6416889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
